Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA study.

MLA

Niho, Seiji, et al. “Randomized Phase II Study of Chemoradiotherapy with Cisplatin + S-1 versus Cisplatin + Pemetrexed for Locally Advanced Non-Squamous Non-Small Cell Lung Cancer: SPECTRA Study.” Lung Cancer (Amsterdam, Netherlands), vol. 141, Mar. 2020, pp. 64–71. EBSCOhost, https://doi.org/10.1016/j.lungcan.2020.01.008.

APA

Niho, S., Yoshida, T., Akimoto, T., Sakamaki, K., Ono, A., Seto, T., Nishio, M., Yamamoto, N., Hida, T., Okamoto, H., Kurata, T., Satouchi, M., Goto, K., Yamanaka, T., & Ohe, Y. (2020). Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA study. Lung Cancer (Amsterdam, Netherlands), 141, 64–71. https://doi.org/10.1016/j.lungcan.2020.01.008

Chicago

Niho, Seiji, Tatsuya Yoshida, Tetsuo Akimoto, Kentaro Sakamaki, Akira Ono, Takashi Seto, Makoto Nishio, et al. 2020. “Randomized Phase II Study of Chemoradiotherapy with Cisplatin + S-1 versus Cisplatin + Pemetrexed for Locally Advanced Non-Squamous Non-Small Cell Lung Cancer: SPECTRA Study.” Lung Cancer (Amsterdam, Netherlands) 141 (March): 64–71. doi:10.1016/j.lungcan.2020.01.008.